Ray Dalio Meridian Bioscience Inc Transaction History

Bridgewater Associates, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$31.15 - $33.39 $539,580 - $578,381	-17,322 Reduced 25.42%	50,827 $1.69 Million
Q3 2022 Nov 10, 2022	SELL	$30.9 - $33.55 $8,590 - $9,326	-278 Reduced 0.41%	68,149 $2.15 Million
Q2 2022 Aug 11, 2022	BUY	$23.75 - $31.69 $147,226 - $196,446	6,199 Added 9.96%	68,427 $2.08 Million
Q1 2022 May 13, 2022	BUY	$19.97 - $26.94 $286,170 - $386,050	14,330 Added 29.92%	62,228 $1.62 Million
Q4 2021 Feb 14, 2022	BUY	$17.46 - $21.61 $36,351 - $44,992	2,082 Added 4.54%	47,898 $977,000

Q3 2021 Nov 12, 2021	BUY	$17.35 - $22.5 $3,053 - $3,960	176 Added 0.39%	45,816 $881,000
Q2 2021 Aug 13, 2021	BUY	$18.01 - $28.32 $821,976 - $1.29 Million	45,640 New	45,640 $1.01 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.